Table 2 Changes of main variables from baseline to 6 months after intervention
From: Effect of royal jelly ingestion for six months on healthy volunteers
RJ | Control | Pvalue | |
|---|---|---|---|
BMI (kg/m2) | +0.1±0.2 | +0.0±0.2 | 0.8389 |
Waist circumference (cm) | -2.1±0.6 | -2.0±0.7 | 0.9115 |
Systolic BP (mmHg) | -0±3 | -1±3 | 0.8732 |
Diastolic BP (mmHg) | +0±2 | -1±2 | 0.6321 |
WBC (/μL) | +570±270 | +320±300 | 0.5661 |
RBC (x106/μL) | +0.16±0.04 | -0.01±0.05 | 0.0134* |
Hb (g/dL) | +0.8±0.2 | +0.3±0.2 | 0.0548 |
Ht (%) | +0.9±0.5 | -0.8±0.5 | 0.0251* |
PLT (x103/μL) | +1±+1 | +1±1 | 0.5809 |
log TG (log mg/dL) | +0.04±0.06 | -0.05±0.07 | 0.3323 |
HDL-C (mg/dL) | +2±2 | -1±2 | 0.2586 |
LDL-C (mg/dL) | +9±3 | +4±3 | 0.2690 |
log FPG (log mg/dL) | +0.01±0.01 | +0.05±0.01 | 0.0297* |
log FIRI (log μIU/mL) | +0.05±0.11 | +0.04±0.12 | 0.9486 |
log HbA1c (log %) | -0.0±0.0 | -0.0±0.0 | 0.9945 |
log HOMA-IR | +0.07±0.11 | +0.08±0.13 | 0.9296 |
log HOMA-B | +0.02±0.10 | -0.05±0.11 | 0.6027 |
log IGI | +0.25±0.11 | -0.13±0.12 | 0.0319* |
log DHEA-S (log μg/dL) | +0.08±0.04 | +0.20±0.04 | 0.0483* |
male | +0.06±0.06 | +0.22±0.07 | 0.1517 |
female | +0.11±0.04 | +0.17±0.05 | 0.4672 |
log T (log ng/mL) | +0.12±0.04 | -0.02±0.05 | 0.0416 |
male | +0.06±0.03 | -0.06±0.03 | 0.0503 |
female | +0.24±0.10 | -0.02±0.11 | 0.1369 |
log E2 (log pg/mL) | -0.01±0.04 | +0.04±0.04 | 0.3955 |
male | +0.02±0.06 | +0.07±0.06 | 0.6303 |
female | -0.06±0.06 | +0.03±0.07 | 0.3756 |
log T/DHEAS | +0.05±0.05 | -0.23±0.59 | 0.0015* |
male | -0.01±0.06 | -0.27±0.06 | 0.0153* |
female | +0.12±0.10 | -0.19±0.12 | 0.0848 |
log E2/T | -0.11±0.06 | +0.04±0.06 | 0.1034 |
male | +0.01±0.07 | +0.09±0.07 | 0.4745 |
female | -0.28±0.11 | +0.02±0.13 | 0.1353 |
SF-36 subscale scores | |||
PF | +2±1 | -1±1 | 0.1384 |
RP | -6±3 | -4±3 | 0.6050 |
BP | +0±4 | -4±4 | 0.4701 |
GH | +16±12 | -6±14 | 0.2856 |
VT | +7±3 | -1±3 | 0.0924 |
SF | -1±4 | -6±4 | 0.4395 |
RE | -3±3 | -4±3 | 0.8287 |
MH | +4±3 | -7±3 | 0.0276* |